AVTR - Illumina: Not All Rests With The Grail Acquisition
- The commentary surrounding Illumina seems to believe its fate stems on the Grail transaction.
- Nothing changes materially for the company if it fails, given strengths in the core business and key wins at the start of FY2021.
- This fundamental momentum is under-reflected in ILMN shares at the present time, by estimation.
- We see a near-term price target of $505, and see a fair value of $519 when discounting future cash flows to the present.
- Here, we cover all of the moving parts in the investment debate for investors' own reasoning.
For further details see:
Illumina: Not All Rests With The Grail Acquisition